Effect of Treatment for 12 Weeks With Rilapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, on Arterial Inflammation as Assessed With18 F-Fluorodeoxyglucose-Positron Emission Tomography Imaging

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2014, Vol.63 (1), p.86-88
Main Authors: Tawakol, Ahmed, MD, Singh, Parmanand, MD, Rudd, James H.F., PhD, Soffer, Joseph, MD, Cai, Gengqian, PhD, Vucic, Esad, MD, Brannan, Sarah P., DPhil, Tarka, Elizabeth A., MD, Shaddinger, Bonnie C., PharmD, Sarov-Blat, Lea, PhD, Matthews, Paul, MD, Subramanian, Sharath, MD, Farkouh, Michael, MD, Fayad, Zahi A., PhD
Format: Article
Language:English
Subjects:
Cardiovascular
Internal Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 88
container_issue 1
container_start_page 86
container_title Journal of the American College of Cardiology
container_volume 63
creator Tawakol, Ahmed, MD
Singh, Parmanand, MD
Rudd, James H.F., PhD
Soffer, Joseph, MD
Cai, Gengqian, PhD
Vucic, Esad, MD
Brannan, Sarah P., DPhil
Tarka, Elizabeth A., MD
Shaddinger, Bonnie C., PharmD
Sarov-Blat, Lea, PhD
Matthews, Paul, MD
Subramanian, Sharath, MD
Farkouh, Michael, MD
Fayad, Zahi A., PhD
description
doi_str_mv 10.1016/j.jacc.2013.07.050
format article
fullrecord <record><control><sourceid>elsevier</sourceid><recordid>TN_cdi_elsevier_clinicalkeyesjournals_1_s2_0_S0735109713030817</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0735109713030817</els_id><sourcerecordid>1_s2_0_S0735109713030817</sourcerecordid><originalsourceid>FETCH-elsevier_clinicalkeyesjournals_1_s2_0_S07351097130308173</originalsourceid><addsrcrecordid>eNqlUNtKw0AQzYOC9fIDPs0HNHE3oU37IhRpseBD0UIfwzSZJJNuMmF3K_Yf_SgT8Q-EgcMczgVOEDxqFWml509N1GCeR7HSSaTSSM3UVTBRaTILtVqmN8Gtc41Sar7Qy0nwvS5Lyj1ICXtL6FvqPJRiQcdwIDo5OLCv4Z0N9gYLPk4B4Y176a144i5cOSc5o6cCdrW4vhbDPTqCVQzbruYje7FTkA5W1pNlNANdGmxb9Dyw6GCIoOGK3yq9gE24MWexUpB8XSpzzsVRuBPH3g6GdcvOjc69tFJZ7OsLbFusuKvug-sSjaOHP7wLnjfr_ctrSMPzyWSz3HDHOZoTXcg1crbdoMt05uJMZR_jSONGOlGJWug0-XfADxC8g6M</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Effect of Treatment for 12 Weeks With Rilapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, on Arterial Inflammation as Assessed With18 F-Fluorodeoxyglucose-Positron Emission Tomography Imaging</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Tawakol, Ahmed, MD ; Singh, Parmanand, MD ; Rudd, James H.F., PhD ; Soffer, Joseph, MD ; Cai, Gengqian, PhD ; Vucic, Esad, MD ; Brannan, Sarah P., DPhil ; Tarka, Elizabeth A., MD ; Shaddinger, Bonnie C., PharmD ; Sarov-Blat, Lea, PhD ; Matthews, Paul, MD ; Subramanian, Sharath, MD ; Farkouh, Michael, MD ; Fayad, Zahi A., PhD</creator><creatorcontrib>Tawakol, Ahmed, MD ; Singh, Parmanand, MD ; Rudd, James H.F., PhD ; Soffer, Joseph, MD ; Cai, Gengqian, PhD ; Vucic, Esad, MD ; Brannan, Sarah P., DPhil ; Tarka, Elizabeth A., MD ; Shaddinger, Bonnie C., PharmD ; Sarov-Blat, Lea, PhD ; Matthews, Paul, MD ; Subramanian, Sharath, MD ; Farkouh, Michael, MD ; Fayad, Zahi A., PhD</creatorcontrib><identifier>ISSN: 0735-1097</identifier><identifier>DOI: 10.1016/j.jacc.2013.07.050</identifier><language>eng</language><subject>Cardiovascular ; Internal Medicine</subject><ispartof>Journal of the American College of Cardiology, 2014, Vol.63 (1), p.86-88</ispartof><rights>American College of Cardiology Foundation</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids></links><search><creatorcontrib>Tawakol, Ahmed, MD</creatorcontrib><creatorcontrib>Singh, Parmanand, MD</creatorcontrib><creatorcontrib>Rudd, James H.F., PhD</creatorcontrib><creatorcontrib>Soffer, Joseph, MD</creatorcontrib><creatorcontrib>Cai, Gengqian, PhD</creatorcontrib><creatorcontrib>Vucic, Esad, MD</creatorcontrib><creatorcontrib>Brannan, Sarah P., DPhil</creatorcontrib><creatorcontrib>Tarka, Elizabeth A., MD</creatorcontrib><creatorcontrib>Shaddinger, Bonnie C., PharmD</creatorcontrib><creatorcontrib>Sarov-Blat, Lea, PhD</creatorcontrib><creatorcontrib>Matthews, Paul, MD</creatorcontrib><creatorcontrib>Subramanian, Sharath, MD</creatorcontrib><creatorcontrib>Farkouh, Michael, MD</creatorcontrib><creatorcontrib>Fayad, Zahi A., PhD</creatorcontrib><title>Effect of Treatment for 12 Weeks With Rilapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, on Arterial Inflammation as Assessed With18 F-Fluorodeoxyglucose-Positron Emission Tomography Imaging</title><title>Journal of the American College of Cardiology</title><subject>Cardiovascular</subject><subject>Internal Medicine</subject><issn>0735-1097</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqlUNtKw0AQzYOC9fIDPs0HNHE3oU37IhRpseBD0UIfwzSZJJNuMmF3K_Yf_SgT8Q-EgcMczgVOEDxqFWml509N1GCeR7HSSaTSSM3UVTBRaTILtVqmN8Gtc41Sar7Qy0nwvS5Lyj1ICXtL6FvqPJRiQcdwIDo5OLCv4Z0N9gYLPk4B4Y176a144i5cOSc5o6cCdrW4vhbDPTqCVQzbruYje7FTkA5W1pNlNANdGmxb9Dyw6GCIoOGK3yq9gE24MWexUpB8XSpzzsVRuBPH3g6GdcvOjc69tFJZ7OsLbFusuKvug-sSjaOHP7wLnjfr_ctrSMPzyWSz3HDHOZoTXcg1crbdoMt05uJMZR_jSONGOlGJWug0-XfADxC8g6M</recordid><startdate>2014</startdate><enddate>2014</enddate><creator>Tawakol, Ahmed, MD</creator><creator>Singh, Parmanand, MD</creator><creator>Rudd, James H.F., PhD</creator><creator>Soffer, Joseph, MD</creator><creator>Cai, Gengqian, PhD</creator><creator>Vucic, Esad, MD</creator><creator>Brannan, Sarah P., DPhil</creator><creator>Tarka, Elizabeth A., MD</creator><creator>Shaddinger, Bonnie C., PharmD</creator><creator>Sarov-Blat, Lea, PhD</creator><creator>Matthews, Paul, MD</creator><creator>Subramanian, Sharath, MD</creator><creator>Farkouh, Michael, MD</creator><creator>Fayad, Zahi A., PhD</creator><scope/></search><sort><creationdate>2014</creationdate><title>Effect of Treatment for 12 Weeks With Rilapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, on Arterial Inflammation as Assessed With18 F-Fluorodeoxyglucose-Positron Emission Tomography Imaging</title><author>Tawakol, Ahmed, MD ; Singh, Parmanand, MD ; Rudd, James H.F., PhD ; Soffer, Joseph, MD ; Cai, Gengqian, PhD ; Vucic, Esad, MD ; Brannan, Sarah P., DPhil ; Tarka, Elizabeth A., MD ; Shaddinger, Bonnie C., PharmD ; Sarov-Blat, Lea, PhD ; Matthews, Paul, MD ; Subramanian, Sharath, MD ; Farkouh, Michael, MD ; Fayad, Zahi A., PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-elsevier_clinicalkeyesjournals_1_s2_0_S07351097130308173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Cardiovascular</topic><topic>Internal Medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tawakol, Ahmed, MD</creatorcontrib><creatorcontrib>Singh, Parmanand, MD</creatorcontrib><creatorcontrib>Rudd, James H.F., PhD</creatorcontrib><creatorcontrib>Soffer, Joseph, MD</creatorcontrib><creatorcontrib>Cai, Gengqian, PhD</creatorcontrib><creatorcontrib>Vucic, Esad, MD</creatorcontrib><creatorcontrib>Brannan, Sarah P., DPhil</creatorcontrib><creatorcontrib>Tarka, Elizabeth A., MD</creatorcontrib><creatorcontrib>Shaddinger, Bonnie C., PharmD</creatorcontrib><creatorcontrib>Sarov-Blat, Lea, PhD</creatorcontrib><creatorcontrib>Matthews, Paul, MD</creatorcontrib><creatorcontrib>Subramanian, Sharath, MD</creatorcontrib><creatorcontrib>Farkouh, Michael, MD</creatorcontrib><creatorcontrib>Fayad, Zahi A., PhD</creatorcontrib><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tawakol, Ahmed, MD</au><au>Singh, Parmanand, MD</au><au>Rudd, James H.F., PhD</au><au>Soffer, Joseph, MD</au><au>Cai, Gengqian, PhD</au><au>Vucic, Esad, MD</au><au>Brannan, Sarah P., DPhil</au><au>Tarka, Elizabeth A., MD</au><au>Shaddinger, Bonnie C., PharmD</au><au>Sarov-Blat, Lea, PhD</au><au>Matthews, Paul, MD</au><au>Subramanian, Sharath, MD</au><au>Farkouh, Michael, MD</au><au>Fayad, Zahi A., PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of Treatment for 12 Weeks With Rilapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, on Arterial Inflammation as Assessed With18 F-Fluorodeoxyglucose-Positron Emission Tomography Imaging</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2014</date><risdate>2014</risdate><volume>63</volume><issue>1</issue><spage>86</spage><epage>88</epage><pages>86-88</pages><issn>0735-1097</issn><doi>10.1016/j.jacc.2013.07.050</doi></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2014, Vol.63 (1), p.86-88
issn 0735-1097
language eng
recordid cdi_elsevier_clinicalkeyesjournals_1_s2_0_S0735109713030817
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS
subjects Cardiovascular
Internal Medicine
title Effect of Treatment for 12 Weeks With Rilapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, on Arterial Inflammation as Assessed With18 F-Fluorodeoxyglucose-Positron Emission Tomography Imaging
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T08%3A58%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20Treatment%20for%2012%20Weeks%20With%20Rilapladib,%20a%20Lipoprotein-Associated%20Phospholipase%20A2%20Inhibitor,%20on%20Arterial%20Inflammation%20as%20Assessed%20With18%20F-Fluorodeoxyglucose-Positron%20Emission%20Tomography%20Imaging&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Tawakol,%20Ahmed,%20MD&rft.date=2014&rft.volume=63&rft.issue=1&rft.spage=86&rft.epage=88&rft.pages=86-88&rft.issn=0735-1097&rft_id=info:doi/10.1016/j.jacc.2013.07.050&rft_dat=%3Celsevier%3E1_s2_0_S0735109713030817%3C/elsevier%3E%3Cgrp_id%3Ecdi_FETCH-elsevier_clinicalkeyesjournals_1_s2_0_S07351097130308173%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true